MRK vs PANW: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Palo Alto Networks, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Merck & Co., Inc. · Healthcare
$119.07
-4.0% upside to fair value
Grade D
High Quality
VS
Palo Alto Networks, Inc. · Technology
$174.96
+15.2% upside to fair value
Grade B
High Quality
QuantHub Verdict
PANW has more upside to fair value
(+15.2%).
MRK trades at a lower forward P/E
(16.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
PANW |
| Current Price |
$119.07 |
$174.96 |
| Fair Value Estimate |
$114.30 |
$201.61 |
| Upside to Fair Value |
-4.0%
|
+15.2%
|
| Market Cap |
$294.4B |
$119.2B |
| Forward P/E |
16.2x
|
94.9x
|
| EV / EBITDA |
12.6x
|
52.4x
|
| Price / Sales |
4.5x
|
12.1x
|
| Price / FCF |
23.8x
|
29.3x
|
| Revenue Growth YoY |
+5.0%
|
+14.9%
|
| Gross Margin |
81.5%
|
73.5%
|
| Operating Margin |
41.2%
|
14.4%
|
| Return on Equity |
36.2%
|
15.5%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.2%
|
3.41%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, particularly oncology and vaccines. The company benefits from a strong business quality characterized by a durable competitive moat, high gross margins of 81.5%, and a robust return on equity of 36.2%. Despite these strengths, the stock is currently fairly valued but slightly overvalued by 4% relative to its…
Palo Alto Networks is a leading cybersecurity company specializing in AI-driven cloud security platforms, subscription services, and hardware products. The company benefits from a durable competitive moat driven by its platform transformation under CEO Nikesh Arora, with over 50% of revenue from high-margin subscription services growing at 25.6% year-over-year in fiscal 2024. Despite a premium va…
Accumulation Zones
| Metric |
MRK |
PANW |
| Zone Low |
$85.72 |
$151.21 |
| Zone High |
$97.16 |
$171.37 |
| In Buy Zone? |
No
|
No
|